The latest closing stock price for Aquestive Therapeutics as of September 18, 2024 is 4.95.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-692 today, roughly -1 times their original investment - a -17.80% compound annual growth rate over 6 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 25.9% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 1.25, which is 74.7% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 2.98.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-692 today, roughly -1 times their original investment - a -17.80% compound annual growth rate over 6 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 25.9% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 1.25, which is 74.7% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 2.98.